Clinical Trials Logo
  1. Home
  2. Onychomycosis
  3. NCT00777868
  4. Details
NCT00777868 Clinical Trial

A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-108 in Patients With Onychomycosis

Onychomycosis Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00777868
Other study ID # DPSI-IDP-108-P2-01
Secondary ID
Status Completed
Phase Phase 2
First received October 20, 2008
Last updated June 20, 2012
Start date October 2007
Est. completion date April 2009

Study information
Verified date June 2012
Source Dow Pharmaceutical Sciences
Contact n/a
Is FDA regulated No
Health authority Mexico: Ministry of Health
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the safety and effectiveness of two concentrations of IDP-108 in treating patients with onychomycosis

Recruitment information / eligibility
Status Completed
Enrollment 135
Est. completion date April 2009
Est. primary completion date April 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Presence of onychomycosis of the target toenail

- A positive fungal culture from the target toenail

Exclusion Criteria:

- Any disease or condition that might cause nail abnormalities or may interfere with clinical evaluations

- Presence of tinea pedis (athletes foot)

- Female subjects who are pregnant, nursing, planning a pregnancy, or become pregnant during the study

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Drug:
• Low Strength IDP-108
Topical application once a day for 9 months
• High Strength IDP-108
Topical application once a day for 9 months
• High Strength IDP-108 under occlusion
Topical application once a day for 9 months
• Vehicle
Topical application once a day for 9 months

Locations
Country Name City State
Mexico Unidad de Investigación en Salud Chihuahua
Mexico Instituto Dermatólogico de Jalisco "Dr. Jose Barba Rubio" Guadalajara Jalisco
Mexico Clinical Research Institute Mexico City Federal District
Mexico Hospital Central Militar Mexico City Federal District
Mexico Hospital General de México México City Federal District
Mexico Centro de Dermatología de Monterrey Monterrey Nuevo León
Mexico Hospital Universitario "José E. González" Monterrey Nuevo León
Mexico MIRC/OCA Hospital Monterrey Nuevo León
Mexico Hospital Ignacio Morones Prieto SLP San Luis Potosí
Mexico Hospital Dr. Ángel Leaño Zapopan Jalisco

Sponsors (1)
Lead Sponsor Collaborator
Dow Pharmaceutical Sciences

Country where clinical trial is conducted

Mexico, 

Outcome
Type Measure Description Time frame Safety issue
Primary Change from baseline in area of infected nail 9 months No
Secondary Change from baseline in mycological results 9 months No
See also
  Status Clinical Trial Phase
Completed NCT03098615 - Study Evaluating the Effect of Jublia on Dermatophytomas Phase 4
Recruiting NCT01666002 - Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser N/A
Terminated NCT01208168 - Safety & Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails Phase 3
Completed NCT01180491 - A Clinical Investigation on Early Visible Effects of Application of K101 During 8 Weeks on Discoloured and Deformed Nails Resulting From Onychomycosis N/A
Terminated NCT01208129 - Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails Phase 3
Completed NCT00385502 - A Trial of the Safety and Efficacy of EcoNail™ in the Treatment of Fungus Infections of the Great Toenail Phase 2
Completed NCT00253305 - Topical Gel Anti-Fungal Agent for Tinea Unguium Phase 2
Not yet recruiting NCT05809297 - Diode Laser and Photodynamic Therapy Vs. Ciclopirox. Phase 4
Completed NCT03405818 - An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents Phase 4
Completed NCT02588599 - A Retrospective Analysis of the Effects of Low Level Laser Therapy on Toenail Onychomycosis N/A
Recruiting NCT02436291 - Evaluation of the Efficacy of CURE-EX Treatment in Onychomycosis Phase 4
Completed NCT01851590 - Resin vs. Amorolfine vs. Terbinafine Treatment in Onychomycosis Phase 4
Completed NCT01452490 - Diode Laser Treatment of Onychomycosis N/A
Withdrawn NCT00938925 - Effectiveness of Podiatry Care on Onychomycosis (EPOCAON) N/A
Recruiting NCT00808366 - Efficacy and Safety of RV4104A Ointment in Onychomycosis N/A
Completed NCT00781820 - Comparative Efficacy of Bifonazole Cream vs Placebo After Nail Ablation With Urea Paste Phase 3
Completed NCT00768768 - Iontophoretic Application of Terbinafine Gel to the Large Toe Nail Phase 1
Recruiting NCT06074315 - Evaluation of the Effectiveness of Nail Genesis DLSO Product for Onychomycosis N/A
Completed NCT01039883 - A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule Phase 1
Suspended NCT05491603 - A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis Phase 2